Co-Located Conference AgendasDrug Discovery and Development India | MedChem India | NanoPharmaceuticals | 
Wednesday, 9 September 201515:00 | Inauguration | 15:15 |  | Keynote Presentation Title to be Finalized
Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International, United States of America
|
| 15:30 | | 17:00 | Coffee Break and Networking | 17:30 |  | Keynote Presentation Translational Strategies in Oncology & Allied Areas
Anu Singh, Vice President R&D, Dabur Research Foundation, India
|
| 19:30 | Networking Dinner |
Thursday, 10 September 2015 |
Session I: Plenary Session (Combined Session) |
| | 09:15 | | 10:00 |  | Keynote Presentation Role of Host Membrane Cholesterol in Pathogen Entry: A Tale of Two Pathogens
Amitabha Chattopadhyay, Outstanding Scientist (Director Level), Centre for Cellular & Molecular Biology, India
|
| 10:45 |  Technology Spotlight:
Accelerate Your Drug Discovery Process with Maybridge Screening Collections and Fragment Libraries
Simon Pearce, Global Product Manager, ThermoFisher Scientific
| 11:05 |  Technology Spotlight:
Automation Tools for Drug Discovery
Basavaraj Gadag, Director, eDiscovery Automation Pvt Ltd
| 11:20 | Coffee Break and Networking in Exhibition Area | |
Session II: Drug Discovery - From Natural Products to Translational Research |
| | 11:50 | | 12:35 |  | Keynote Presentation Annotating Biological Activities of Drugs, Natural Products, and Environmental Toxicants by the FACTORIAL™ Pathway Profiling Platform
Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America
|
| 13:20 | Future Trends and Challenges in Innovative Translational Research: Academic and Industrial Perspective
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences, India
This talk highlights the current state of translational research worldwide including what academia and industry should do in order to achieve better, faster translational results for the benefit of both patients and themselves. | 13:55 | Lunch Break and Networking in Exhibition Area | |
Session III: Novel Therapeutic Targets |
| | 14:55 |  | Keynote Presentation Antimalarial Drug Discovery and the Possibilities of Exploiting the Apicoplast Biosynthetic Pathways
Prati Pal Singh, Professor, NIPER Mohali, India
|
| 15:40 | Cytokines and their Signalling Pathways as Therapeutic Targets in Drug Discovery for Inflammatory Disorders: Focus on Atherosclerosis
Dipak Ramji, Professor, Cardiff University, United Kingdom
This talk will elaborate the Novel insights into intracellular signalling pathways. Cytokines will be discussed in the context of current therapies and future drug discovery and development. In this presentation many conventional therapies, such as statins and nutraceuticals, that modulate cytokine signalling will also be discussed. The limitation of cytokine therapeutics and the possibility of approaches involving modulation of cells that produce anti-atherogenic cytokines will also be presented.
| 16:15 | Coffee Break and Networking in Exhibition Area | |
Session IV: Drug Design - Advances & Challenges |
| | 16:30 | Current Status of Computational Drug designing and Challenges for Next Millennium
Prakash Jha, Assistant Professor, Central University of Gujarat, India
| 17:05 |  | Keynote Presentation Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo, Norway
|
|
Friday, 11 September 2015 |
Session V: Updates on Pre-clinical Drug Discovery |
| | 09:30 | Role of Polymorphs in Drug Discovery
Keshav Deo, Senior Vice President, Wockhardt Research Center, India
| 10:05 | Pre-clinical Drug Development
Punit Srivastava, Assistant Director, Daiichi Sankyo India Pharma Pvt Ltd, India
| 10:40 | ADMET Technologies in Drug Design and Discovery: Helping the Medicinal Chemist in Optimal Drug Design
Subrahmanyam Vangala, Founder and Chief Executive Officer, ReaGene Biosciences Private Limited, India
This talk will focus on how ADMET technologies have evolved in the past twenty years while becoming very critical for Medicinal Chemists to design novel NCEs. | 11:15 | Coffee Break and Networking in Exhibition Area | |
Session VI: Novel Approaches to Drug Discovery |
| | 11:45 | Novel Screening Methodologies for Drug Discovery
Rakesh Rawal, Senior Scientific Officer & Head, The Gujarat Cancer & Research Institute, India
| 12:20 | Fragment Based Approaches in Drug Discovery
Sridhar Radhakrishnan , Research Fellow , Cancer Science Institute of Singapore , Singapore
| 12:55 | Pharmaceutical Industries Continued Love Affair with Cholestrol
Shanavas Alikunju, Vice President & Head - Translational R&D and Biology, Dr. Reddy's Laboratories Ltd, India
| 13:30 | Poster Viewing | 13:50 | Lunch Break and Networking in Exhibition Area | |
Session VII: Designing Drugs for Neglected Diseases |
| | 14:50 | Design and Synthesis of Novel Therapeutic Agents
Prem M S Chauhan, Professor (AcSIR), Central Drug Research Institute, India
This presentation highlights about the development of biologically active scaffolds as antiparasitic agents. The design, synthesis and antiparasitic activity of the novel therapeutic agents will also be discussed. | 15:35 | Discovery Approaches for Neglected Tropical Diseases
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India
| 16:00 | Coffee Break and Networking in Exhibition Area | 16:20 | Panel Discussion |
|
Add to Calendar ▼2015-09-09 00:00:002015-09-11 00:00:00Europe/LondonDrug Discovery and Development IndiaDrug Discovery and Development India in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com
